Hongliang Li

机构：Jiangnan University, Capital Medical University, First Affiliated Hospital of Gannan Medical University, Beijing Shijitan Hospital · ORCID：0000-0002-9821-0297

发表论文 510 篇 · 总被引 31631 次 · h-index 82

代表论文

• Lymphoplasmapheresis for Steroid‐Refractory Neuromyelitis Optica Spectrum Disorder: A Real‐World Multicenter Study in China (2025 · CNS Neuroscience & Therapeutics · 被引 9)
• Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD (2025 · Gut · 被引 8)
• Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction–associated steatohepatitis (2025 · Journal of Clinical Investigation · 被引 7)
• Icaritin inhibits osteoclast differentiation and reduces bone loss by targeting ESR1 to inhibit miR503/RANK pathway (2025 · Frontiers in Pharmacology · 被引 4)
• Chlorinated Guaiane-Type Sesquiterpene Lactones of Natural Origin (2025 · Journal of Natural Products · 被引 4)
• Global, regional, and national burden of acute hepatitis (1990–2021): a systematic analysis of the global burden of disease in 2021 (2025 · Frontiers in Medicine · 被引 4)